[ad_1]
reOnald Trump is now “in a race” against the coronavirus, according to the CEO of the pharmaceutical company that provided the experimental drug the president is taking.
Dr. Leonard Schleifer’s biotech company Regeneron developed the experimental antibody treatment that was administered to Trump on Friday, before he was taken to the hospital.
Schleifer told CNN: “He’s in a race where his immune system is competing against the virus, and if the virus wins, obviously it can have dire consequences, and what our antibodies do is we make it a fair fight.” .
“He’s in a higher risk group for a variety of reasons, like being older, and if we give him our antibodies, we hope to give his immune system a sufficient boost so that he can gain this and make a full recovery.” Dr. Schleifer said.
“That is the strategy. We have a lot of data, but we are still in the experimental phase, but when you are in the middle of a pandemic and you have people at risk, we think it makes sense to test it, “he added.
[ad_2]
